Simulation of early after-depolarisation in non-failing human ventricular myocytes: Can this help cardiac safety pharmacology?-Reference-Cited by-同舟云学术

Simulation of early after-depolarisation in non-failing human ventricular myocytes: Can this help cardiac safety pharmacology?

Published:2013-09 Issue:5 Volume:65 Page:1281-1293
ISSN:1734-1140
Container-title:Pharmacological Reports
language:en
Short-container-title:Pharmacological Reports

Author:

Christophe Bernard

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology,General Medicine

Reference43 articles.

1. KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early after-depolarisations in rabbit heart;Anderson;J Pharmacol Exp Ther,1998

2. International Life Sciences Institute (Health and Environmental Sciences Institute HESI) initiative on moving towards better predictors of drug-induced torsades de pointes;Bass;Br J Pharmacol,2008

3. Exploratory safety pharmacology: a new safety paradigm to de-risk drug candidates prior to selection for regulatory science investigations;Cavero;Expert Opin Drug Saf,2009

4. Use of arterially perfused rabbit ventricular wedge in predicting arrhythmogenic potentials of drugs;Chen;J Pharmacol Toxicol Methods,2006

5. Calcium and cardiac arrhythmias: DADs, EADs and alternans;Clusin;Crit Rev Clin Lab Sci,2003

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The importance of mechanical conditions in the testing of excitation abnormalities in a population of electro-mechanical models of human ventricular cardiomyocytes;Frontiers in Physiology;2023-06-08

2. Occurrence of early afterdepolarization under healthy or hypertrophic cardiomyopathy conditions in the human ventricular endocardial myocyte: In silico study using 109 torsadogenic or non-torsadogenic compounds;Toxicology and Applied Pharmacology;2022-03

3. A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane;European Journal of Pharmacology;2020-09

4. General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico Strategy;Clinical Pharmacology & Therapeutics;2019-11-10

5. Global Sensitivity Analysis of Ventricular Myocyte Model-Derived Metrics for Proarrhythmic Risk Assessment;Frontiers in Pharmacology;2019-10-02